Capricor Therapeutics:可用现金、现金等价物及有价证券足以支撑其运营至2027年第四季度

美股速递
May 13

生物技术公司Capricor Therapeutics Inc. 宣布,其当前持有的可用现金、现金等价物及市场流通有价证券,预计足以覆盖公司运营支出及资本需求,直至2027年第四季度。这一资金状况为公司推进其核心研发管线提供了坚实的财务保障。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10